杂交入路髂股动脉内膜剥脱术治疗严重及完全闭塞性病变
单中心回顾性研究纳入51例患者共63条肢体,评估荧光透视下逆行髂股动脉内膜剥脱联合支架置入的杂交术式。
要点
- 杂交髂股动脉内膜剥脱联合选择性支架置入可显著改善严重髂动脉闭塞患者的血流动力学。
- 作者建议将广泛内膜剥脱联合选择性支架置入作为严重髂动脉闭塞的一线微创治疗。
核心结论
- 广泛杂交逆行髂股动脉内膜剥脱联合支架置入治疗严重髂动脉闭塞性疾病安全有效,早期结局优异。
研究设计与样本
- 共51例患者63条肢体,其中33条肢体为 критическая肢端缺血(17条组织缺损/坏疽,16条静息痛),30条为生活方式受限的间歇性跛行。
- 病变按TASC II分型:84%为D型,16%为C型。
主要发现
- 踝肱指数从0.42 ± 0.25显著改善至0.73 ± 0.27(P < .001)。
- 趾压从29 ± 27 mm Hg显著改善至59 ± 34 mm Hg(P < .001)。
- 68%的肢体需要髂外动脉支架置入(众数直径10 mm),75%完成同侧髂总动脉支架置入(众数直径9 mm)。
临床怎么用
- 对于严重髂动脉闭塞性疾病(尤其是TASC II C/D型),可考虑采用杂交逆行髂股动脉内膜剥脱联合选择性支架置入作为微创一线治疗。
- 术后应监测踝肱指数和趾压以评估血流动力学改善。
局限性
- 单中心回顾性研究,样本量有限(51例患者63条肢体),结论需更大规模前瞻性研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Primary endovascular approaches are now the dominant modality for the treatment of iliac occlusive disease. However, stenting of the external iliac artery is plagued with high in-stent restenosis rates. This hybrid approach with fluoroscopic, retrograde iliofemoral endarterectomy combined with stenting was previously demonstrated to be both a safe and effective alternative to bypass and primary stenting alone for TransAtlantic Inter-Society Consensus (TASC) II C and D lesions. In this study, early outcomes and hemodynamic improvements of this hybrid approach are evaluated with an expanded patient population. METHODS: This was a single-institution, retrospective review of all hybrid-based retrograde iliofemoral endarterectomies from the common femoral artery extending to the proximal external iliac artery from January 1, 2010, to November 15, 2017. Data were collected from the electronic medical record and analyzed using standard quantitative statistical techniques. All preprocedure and postprocedure imaging was independently reviewed by two vascular surgeons. Variables included patient demographics, degree of ischemia, and stent characteristics. The primary outcomes were mortality and freedom from amputation, with secondary outcomes including changes in the ankle-brachial index and toe pressure. RESULTS: The procedure was performed on 63 limbs in 51 total patients. In 33 limbs, the indication was critical limb ischemia (tissue loss/gangrene = 17, rest pain = 16) and 30 for lifestyle-limiting claudication. The cohort consisted of 84% TASC D and 16% TASC C. External iliac stenting was required in 68% (modal diameter, 10 mm) and ipsilateral common iliac stenting was completed in 75% (modal diameter, 9 mm). The ankle-brachial index significantly improved from 0.42 ± 0.25 to 0.73 ± 0.27 (P < .001) as did toe pressure from 29 ± 27 mm Hg to 59 ± 34 mm Hg (P < .001). Thirteen limbs ultimately required an infrainguinal procedure. One patient experienced an intraoperative iliac perforation that resolved with stenting. One death occurred within 90 days. Ninety-five percent of patients remained free from amputation. CONCLUSIONS: Extensive hybrid-based, retrograde iliofemoral endarterectomy with stenting is a safe and efficacious approach to severe iliac arterial occlusive disease, with excellent early outcomes. This series promulgates the hypothesis that extensive endarterectomy with selective iliac stenting yields superior results to external iliac stenting alone. Given the superb hemodynamic improvements in a larger patient population, this hybrid-based, extensive iliofemoral endarterectomy should be recommended as a minimally invasive, first-line treatment for severe iliac occlusive disease.
引用
- Gowing JM, Heidenreich MJ, Kavanagh CM, et al. Hybrid-based iliofemoral endarterectomy for severe and complete iliofemoral occlusive disease. J Vasc Surg. 2020. PMID: 32707383. doi:10.1016/j.jvs.2020.07.060
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。